# Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine

> **NCT03606356** · PHASE4 · COMPLETED · sponsor: **Corfu Headache Clinic** · enrollment: 56 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Onabotulinum toxin A

## Key facts

- **NCT ID:** NCT03606356
- **Lead sponsor:** Corfu Headache Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606356, "Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03606356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*